EMJ GOLD

Co-founders, Prof Ugur Sahin and Prof Özlem Türeci, will depart to establish a new, independent biotechnology company.

The appointment is tied to the company’s “focused innovator” strategy, seeking to combine human expertise with high-performance computing.

The UK Space Agency, MHRA and the CAA have announced a new regulatory roadmap for in-orbit manufacturing of pharmaceuticals.

The collaboration will leverage kyron.bio’s glycoengineering platform to optimise a specific antibody candidate selected by Servier.

The move aims to transform the nation into a strategic centre for global clinical trials and biotechnology innovation in Asia.

As International Women’s Day approaches, data on the global women’s health market paints a mixed picture.

The hunt for new cystic fibrosis therapies is going digital, as the Cystic Fibrosis Foundation taps Antiverse for AI antibody design.

In this monthly news roundup, we take a look back at top moments from the pharmaceutical industry. It’s time to reflect on February 2026.